TATTENHAM HEALTH CENTRE
TATTENHAM CRESCENT, EPSOMStroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 46 | 51 | 90.2% | |
STROKE 9 | 2006 | 52 | 55 | 94.5% | |
Stroke 12 | 2007 | 49 | 51 | 96.1% | |
Stroke 12 | 2008 | 59 | 60 | 98.3% | |
Stroke 12 | 2009 | 57 | 63 | 90.5% | |
Stroke 12 | 2010 | 61 | 64 | 95.3% | |
STROKE 12 | 2011 | 56 | 59 | 94.9% | |
STROKE 12 | 2012 | 60 | 64 | 93.8% | |
STROKE 12 | 2013 | 50 | 55 | 90.9% | |
STIA007 | 2014 | 60 | 60 | 100.0% | |
STIA007 | 2015 | 62 | 63 | 98.4% | |
STIA007 | 2016 | 69 | 70 | 98.6% | |
STIA007 | 2017 | 62 | 63 | 98.4% | |
STIA007 | 2018 | 64 | 64 | 100.0% | |
STIA007 | 2019 | 73 | 73 | 100.0% | |
STIA007 | 2020 | 83 | 84 | 98.8% | |
STIA007 | 2021 | 81 | 96 | 84.4% | |
STIA007 | 2022 | 87 | 89 | 97.8% | |
STIA007 | 2023 | 102 | 102 | 100.0% |